The EEF1A2 gene expression as risk predictor in localized prostate cancer

BACKGROUND: Besides clinical stage and Gleason score, risk-stratification of prostate cancer in the pretherapeutic setting mainly relies on the serum PSA level. Yet, this is associated with many uncertainties. With regard to therapy decision-making, additional markers are needed to allow an exact ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Worst, Thomas Stefan, Waldbillig, Frank, Abdelhadi, Abdallah, Weis, Cleo-Aron, Gottschalt, Maria, Steidler, Annette, von Hardenberg, Jost, Michel, Maurice Stephan, Erben, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604352/
https://www.ncbi.nlm.nih.gov/pubmed/28923030
http://dx.doi.org/10.1186/s12894-017-0278-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604352/
https://www.ncbi.nlm.nih.gov/pubmed/28923030
http://dx.doi.org/10.1186/s12894-017-0278-3

Ejemplares similares